← The Wire
RLMDNasdaq
RELMADA THERAPEUTICS, INC.
Pharmaceutical Preparations · NV · CIK 1553643
Relmada Therapeutics develops novel drug formulations for bladder cancer and neurological disorders
$698M
Market cap
$6.98
Last close
+4.3%
1D
+1.3%
5D
2.3M
Volume
Price · last 39 sessions-5.8%
May 4L $5.72 · H $7.86Jun 29
272
Total filings
May 28, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 17, 2026DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 11, 2025DEFA14ADEFINITIVE ADDITIONAL MATERIALSApr 9, 2024DEFA14ADEFINITIVE ADDITIONAL MATERIALSMar 31, 2023DEFA14ADEFINITIVE ADDITIONAL MATERIALSFeb 28, 2020DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 28, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 23, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 21, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 15, 2015DEFA14AADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALSDec 14, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 14, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 11, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 11, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 10, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 9, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 9, 2015DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 7, 2015
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Dec 15, 2025: 4 insiders bought $2.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2025 | Traversa SergioChief Executive Officer | Buy | 27,500 | $4.12 | $113K |
| Dec 15, 2025 | Shenouda MagedChief Financial Officer | Buy | 11,665 | $4.12 | $48K |
| Nov 5, 2025 | Shenouda MagedChief Financial Officer | Buy | 500,000 | $2.20 | $1.1M |
| Nov 5, 2025 | Traversa SergioChief Executive Officer | Buy | 272,500 | $2.20 | $600K |
| Nov 5, 2025 | Ence ChuckCAO and COO | Buy | 136,000 | $2.20 | $299K |
| Nov 5, 2025 | Kelly Paul EdwardChief Operating Officer | Buy | 90,000 | $2.20 | $198K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance